Armstrong Fleming & Moore’s Colgate-Palmolive CL Stock Holding History

Armstrong Fleming & Moore’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$254K	Buy	2,984 +7	+0.2%	+$624	0.11%	92
2025 Q4	$235K	Hold	2,977	–	–	0.11%	92
2025 Q3	$238K	Hold	2,977	–	–	0.11%	96
2025 Q2	$271K	Buy	+2,977	New	+$272K	0.15%	86
2025 Q1	–	Sell	-2,977	Closed	-$271K	–	99
2024 Q4	$271K	Hold	2,977	–	–	0.16%	81
2024 Q3	$309K	Hold	2,977	–	–	0.18%	77
2024 Q2	$289K	Sell	2,977 -44	-1%	-$4.06K	0.19%	75
2024 Q1	$272K	Hold	3,021	–	–	0.19%	79
2023 Q4	$241K	Hold	3,021	–	–	0.18%	81
2023 Q3	$215K	Buy	3,021 +1	+0%	+$75	0.21%	79
2023 Q2	$233K	Buy	+3,020	New	+$234K	0.21%	80

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Armstrong Fleming & Moore's CL Position: Q1 2026 in Review

Armstrong Fleming & Moore increased its Colgate-Palmolive (CL) stake by 0.24% in Q1 2026, buying an estimated $624 and bringing the position to 2,984 shares worth $254K. The position accounts for 0.11% of the portfolio, ranked #92.

Armstrong Fleming & Moore first reported a position in CL in Q2 2023 and has held it in 11 quarters since. The position peaked at $309K in Q3 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Armstrong Fleming & Moore held 2,984 shares of Colgate-Palmolive worth $254K as of Q1 2026.
Armstrong Fleming & Moore bought 7 Colgate-Palmolive shares in Q1 2026, an estimated $624.
Colgate-Palmolive made up 0.11% of Armstrong Fleming & Moore's portfolio in Q1 2026, its #92 holding.
Armstrong Fleming & Moore first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 11 quarters since.
Armstrong Fleming & Moore's Colgate-Palmolive position peaked at $309K in Q3 2024.
1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Armstrong Fleming & Moore's 13F filing for Q1 2026, filed 13 Apr 2026.